助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   慢性心脏疾病 的翻译结果: 查询用时:0.022秒
图标索引 在分类学科中查询
所有学科
心血管系统疾病
更多类别查询

图标索引 历史查询
 

慢性心脏疾病
相关语句
  chronic heart diseases
     Relationship between antiarrhythmix peptide and chronic heart diseases.
     抗心律失常肽与慢性心脏疾病的关系
短句来源
  “慢性心脏疾病”译为未确定词的双语例句
     Objective To evaluate the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population.
     目的 观察磷酸奥司他韦在患有慢性呼吸系统疾病和慢性心脏疾病的流行性感冒 (流感 )患者中的临床疗效及安全性。
短句来源
     They should satisfy the following criteria:Fever≥37.8℃ plus at least two of the following influenza symptoms:coryza/nasal congestion,sore throat,cough,myalgia/ muscle aches and pain,fatigue,headache and chills/sweats. Within 48 h after the onset of the symptoms,the patients were randomly assigned to oseltamivir group(oseltamivir 75 mg,twice daily for 5 days) or control group(symptom relief medicine only).
     患有慢性支气管炎、支气管哮喘、支气管扩张、阻塞性肺疾病等慢性呼吸系统疾病或慢性心脏疾病的人群 ,在流感流行季节内有发热≥ 37 8℃并至少有 2项流感样症状 ,在出现症状后 4 8h内 ,合格的受试者随机接受磷酸奥司他韦 75mg ,每天 2次 ,共 5d(试验组 )或只给予对症治疗 (对照组 )。
短句来源
  相似匹配句对
     Tumor necrosis factor-alpha and heart diseases
     肿瘤坏死因子和心脏疾病
短句来源
     Relationship between antiarrhythmix peptide and chronic heart diseases.
     抗心律失常肽与慢性心脏疾病的关系
短句来源
     Cardiac Sodium Channel Diseases
     心脏钠通道疾病
短句来源
     Nutrition and chronic diseases
     营养与慢性疾病
短句来源
     Pathogenic mechanism of anemia of chronic disease
     慢性疾病性贫血的发病机制
短句来源
查询“慢性心脏疾病”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  chronic heart disease
Thus, the usage of telemedicine offers a central instrument for service and information, so that an optimized therapy can be achieved by consequent surveillance of the patient with chronic heart disease.
      
Current issues of gene therapy for cardiovascular disorders and antithrombotic therapy in chronic heart disease
      
The characteristic multifractal pattern in heart transplant recipients or chronic heart disease highlights the importance of neuroautonomic control mechanisms regulating the fractal dynamics of the cardiac rhythm.
      
Chronic heart disease in the elderly and pneumonia seemed to be associated with a fatal outcome.
      
Isolated ischemic necrosis of the cecum in patients with chronic heart disease
      
更多          
  chronic heart diseases
Auricular appendages were obtained from 20 patients ranging in age from 4 to 64 years with chronic heart diseases at the time of operation and observed with an electron microscope.
      
Acute or chronic heart diseases resulting from the insufficient supply of oxygenated blood to the heart.
      


Objective To evaluate the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population. Methods A randomized,open,control trial was conducted from Nov. 2002 to Feb. 2003. Patiensts with chronic respiratory disease,such as chronic bronchitis,obstructive emphysema,bronchial asthma,bronchiectasis or chronic cardiac disease,and with symptoms of influenza were enrolled. They should satisfy the following criteria:Fever≥37.8℃ plus at least two of the following influenza symptoms:coryza/nasal...

Objective To evaluate the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population. Methods A randomized,open,control trial was conducted from Nov. 2002 to Feb. 2003. Patiensts with chronic respiratory disease,such as chronic bronchitis,obstructive emphysema,bronchial asthma,bronchiectasis or chronic cardiac disease,and with symptoms of influenza were enrolled. They should satisfy the following criteria:Fever≥37.8℃ plus at least two of the following influenza symptoms:coryza/nasal congestion,sore throat,cough,myalgia/ muscle aches and pain,fatigue,headache and chills/sweats. Within 48 h after the onset of the symptoms,the patients were randomly assigned to oseltamivir group(oseltamivir 75 mg,twice daily for 5 days) or control group(symptom relief medicine only). Results Fifty-six of the 108 recruited patients were identified as influenza-infected through laboratory test. They were defined as intent-to-treat infected population(ITTI)(27 oseltamivir,29 control). The duration of influenza symptom was 64 h shorter(36.7%) and AUC score of the influenza symptom was decreased by 618(43.1%) in the oseltamivir group as compared with those in the control group. The fever duration was 46.8 h(45.0%) less in the oseltamivir group than that in the control group. It took 6 d for the oseltamivir group and 11 days for the control group to recover to the basic health status. Secondary complications such as bronchitis,sinusitis and pneumonia occurred 11%(3/27) in the oseltamivir group and 45%(13/29) in the control group. The treatment expense for influenza and its complication was 587.4 RMB in the oseltamivir group and 786.5 RMB in the control group,which showed no significant difference(P=0.246). Conclusions It is suggested that oseltamivir is effective and well tolerated in patients with chronic respiratory or cardiac diseases. It can reduce the fever duration and severity of influenza symptom,and decrease the incidence of secondary complications and antibiotic use,while does not increase the total medical cost.

目的 观察磷酸奥司他韦在患有慢性呼吸系统疾病和慢性心脏疾病的流行性感冒 (流感 )患者中的临床疗效及安全性。方法 采用随机、对照、开放性的多中心临床试验设计。患有慢性支气管炎、支气管哮喘、支气管扩张、阻塞性肺疾病等慢性呼吸系统疾病或慢性心脏疾病的人群 ,在流感流行季节内有发热≥ 37 8℃并至少有 2项流感样症状 ,在出现症状后 4 8h内 ,合格的受试者随机接受磷酸奥司他韦 75mg ,每天 2次 ,共 5d(试验组 )或只给予对症治疗 (对照组 )。结果  10 8例受试者中被证实为流感患者 (即感染总体 ,ITTI)共 5 6例 ,其中 (试验组 ) 2 7例 ,对照组 2 9例。试验组和对照组流感症状平均缓解时间分别为 (110± 12 6 )h和 (174± 93)h ,差异有显著性 ,试验组比对照组缩短6 4h(36 7% ) ;症状总评分以曲线下面积 (AUC)表示 ,分别为 (817± 4 6 7)分和 (14 35± 6 4 7)分 ,两组差异有非常显著性 ,试验组比对照组减少 6 18分 (4 3 1% )。两组流感平均发热持续时间分别为 (5 7±4 5 )h和...

目的 观察磷酸奥司他韦在患有慢性呼吸系统疾病和慢性心脏疾病的流行性感冒 (流感 )患者中的临床疗效及安全性。方法 采用随机、对照、开放性的多中心临床试验设计。患有慢性支气管炎、支气管哮喘、支气管扩张、阻塞性肺疾病等慢性呼吸系统疾病或慢性心脏疾病的人群 ,在流感流行季节内有发热≥ 37 8℃并至少有 2项流感样症状 ,在出现症状后 4 8h内 ,合格的受试者随机接受磷酸奥司他韦 75mg ,每天 2次 ,共 5d(试验组 )或只给予对症治疗 (对照组 )。结果  10 8例受试者中被证实为流感患者 (即感染总体 ,ITTI)共 5 6例 ,其中 (试验组 ) 2 7例 ,对照组 2 9例。试验组和对照组流感症状平均缓解时间分别为 (110± 12 6 )h和 (174± 93)h ,差异有显著性 ,试验组比对照组缩短6 4h(36 7% ) ;症状总评分以曲线下面积 (AUC)表示 ,分别为 (817± 4 6 7)分和 (14 35± 6 4 7)分 ,两组差异有非常显著性 ,试验组比对照组减少 6 18分 (4 3 1% )。两组流感平均发热持续时间分别为 (5 7±4 5 )h和 (10 4± 77)h ,两组差异有显著性 (F =7 19,P =0 0 0 98) ,试验组比对照组平均发热持续时间缩短达 4 6 8h(4 5 0 % )。试验组恢复到感染流感前基础状态所需时间平均为 6d ,对照组平均为 11d。并发症的发生率两组分别为 1

 
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关慢性心脏疾病的内容
在知识搜索中查有关慢性心脏疾病的内容
在数字搜索中查有关慢性心脏疾病的内容
在概念知识元中查有关慢性心脏疾病的内容
在学术趋势中查有关慢性心脏疾病的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社